Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Merigan

Showing results (241-250 of 366) with videos related to

Pageof 37
Sort By:
The Journal of Infectious Diseases|October 1, 1994
Failure of short-term CD4-PE40 infusions to reduce virus load in human immunodeficiency virus-infected personsR V Ramachandran, D A Katzenstein, R Wood, et al.
The Journal of Infectious Diseases|March 1, 1993
Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II studyR Wood, J G Montoya, S K Kundu, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responsesB Hafkin, R B Pollard, M L Tiku, et al.
Annals of Internal Medicine|January 1, 1982
UCLA conference. Interferon: immunobiology and clinical significanceE R Stiehm, L H Kronenberg, H M Rosenblatt, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administrationA G Clark, M Holodniy, D H Schwartz, et al.
The Journal of Infectious Diseases|April 1, 1993
Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapyK A Hamed, M A Winters, M Holodniy, et al.
The Journal of Infectious Diseases|April 1, 1996
Polyethylene glycol-modified interleukin-2 and thymosin alpha 1 in human immunodeficiency virus type 1 infectionR Ramachandran, D A Katzenstein, M A Winters, et al.
Journal of Biological Response Modifiers|January 1, 1983
Phase I study of human leukocyte interferon in patients with advanced cancerS J Horning, J F Levine, M Meyer, et al.
The New England Journal of Medicine|June 16, 1977
Cellular immunity and herpesvirus infections in cardiac-transplant patientsK H Rand, L E Rasmussen, R B Pollard, et al.
Experimental Hematology|March 1, 1979
Suppressive effect of interferon on erythroid cell proliferationJ A Ortega, A Ma, N A Shore, et al.
Pageof 37

Showing results (241-250 of 366) with videos related to

Sort By:
Pageof 37
The Journal of Infectious Diseases|October 1, 1994
Failure of short-term CD4-PE40 infusions to reduce virus load in human immunodeficiency virus-infected personsR V Ramachandran, D A Katzenstein, R Wood, et al.
The Journal of Infectious Diseases|March 1, 1993
Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II studyR Wood, J G Montoya, S K Kundu, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1979
Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responsesB Hafkin, R B Pollard, M L Tiku, et al.
Annals of Internal Medicine|January 1, 1982
UCLA conference. Interferon: immunobiology and clinical significanceE R Stiehm, L H Kronenberg, H M Rosenblatt, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rIL-2 administrationA G Clark, M Holodniy, D H Schwartz, et al.
The Journal of Infectious Diseases|April 1, 1993
Detection of human immunodeficiency virus type 1 in semen: effects of disease stage and nucleoside therapyK A Hamed, M A Winters, M Holodniy, et al.
The Journal of Infectious Diseases|April 1, 1996
Polyethylene glycol-modified interleukin-2 and thymosin alpha 1 in human immunodeficiency virus type 1 infectionR Ramachandran, D A Katzenstein, M A Winters, et al.
Journal of Biological Response Modifiers|January 1, 1983
Phase I study of human leukocyte interferon in patients with advanced cancerS J Horning, J F Levine, M Meyer, et al.
The New England Journal of Medicine|June 16, 1977
Cellular immunity and herpesvirus infections in cardiac-transplant patientsK H Rand, L E Rasmussen, R B Pollard, et al.
Experimental Hematology|March 1, 1979
Suppressive effect of interferon on erythroid cell proliferationJ A Ortega, A Ma, N A Shore, et al.
Pageof 37